Sign in
8-K

Current Report

Cartesian Therapeutics, Inc. Filed Acc 0001453687-17-000056

Material agreement · Agreement ended · New debt or obligation · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 1.02 Termination of a material definitive agreement
  • Item 2.03 Creation of a direct financial obligation
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading selectabiosciences8k_ventu.htm…